Ana López‐Alfonso

584 total citations
14 papers, 340 citations indexed

About

Ana López‐Alfonso is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ana López‐Alfonso has authored 14 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ana López‐Alfonso's work include COVID-19 and healthcare impacts (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Ana López‐Alfonso is often cited by papers focused on COVID-19 and healthcare impacts (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Ana López‐Alfonso collaborates with scholars based in Spain. Ana López‐Alfonso's co-authors include Berta Obispo, Cristina Pangua, Jacobo Rogado, Pedro Gullón, Marta Rodríguez, Cristina Peña, Gemma Domínguez, Mariano Provencio, Félix Bonilla and Javier Silva and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Endocrinology.

In The Last Decade

Ana López‐Alfonso

12 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana López‐Alfonso Spain 6 170 126 114 89 74 14 340
Emre Yekedüz Türkiye 9 163 1.0× 41 0.3× 38 0.3× 58 0.7× 107 1.4× 63 296
Clémence Basse France 7 147 0.9× 61 0.5× 23 0.2× 39 0.4× 59 0.8× 27 252
Kristen Labbe United States 6 146 0.9× 63 0.5× 29 0.3× 65 0.7× 51 0.7× 6 233
Nalinie Joharatnam‐Hogan United Kingdom 10 107 0.6× 43 0.3× 40 0.4× 27 0.3× 86 1.2× 14 253
Dana Lucia Stănculeanu Romania 11 179 1.1× 87 0.7× 45 0.4× 23 0.3× 55 0.7× 50 356
Keith A. Dookeran United States 9 116 0.7× 56 0.4× 82 0.7× 36 0.4× 38 0.5× 39 370
Liang G. Qu Australia 9 123 0.7× 43 0.3× 39 0.3× 16 0.2× 61 0.8× 32 326
Simone Navarra Italy 8 140 0.8× 133 1.1× 46 0.4× 31 0.3× 32 0.4× 13 266
Fabian Echterdiek Germany 10 99 0.6× 115 0.9× 67 0.6× 22 0.2× 27 0.4× 23 336
Davide Soldato Italy 10 192 1.1× 50 0.4× 56 0.5× 10 0.1× 94 1.3× 27 303

Countries citing papers authored by Ana López‐Alfonso

Since Specialization
Citations

This map shows the geographic impact of Ana López‐Alfonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana López‐Alfonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana López‐Alfonso more than expected).

Fields of papers citing papers by Ana López‐Alfonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana López‐Alfonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana López‐Alfonso. The network helps show where Ana López‐Alfonso may publish in the future.

Co-authorship network of co-authors of Ana López‐Alfonso

This figure shows the co-authorship network connecting the top 25 collaborators of Ana López‐Alfonso. A scholar is included among the top collaborators of Ana López‐Alfonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana López‐Alfonso. Ana López‐Alfonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pacheco-Barcía, Vilma, Alberto Carmona‐Bayonas, Javier Gállego, et al.. (2024). Nutritional impact and prognostic role of systemic inflammatory response index (SIRI) in advanced pancreatic cancer: PANTHEIA-Spanish Society of Medical Oncology (SEOM) study results.. Journal of Clinical Oncology. 42(3_suppl). 623–623. 1 indexed citations
2.
Martín, Andrés J. Muñoz, L. Ortega Morán, Diego Megı́as, et al.. (2022). Prognosis and correlation with Ca19.9 of circulating tumor cells (CTCs) in locally advanced and metastatic pancreatic cancer.. Journal of Clinical Oncology. 40(4_suppl). 586–586. 1 indexed citations
3.
4.
Obispo, Berta, et al.. (2020). 1771P Do breast cancer patients with COVID-19 have a poor prognosis? Experience in a hospital in Madrid. Annals of Oncology. 31. S1028–S1028. 1 indexed citations
5.
6.
Rogado, Jacobo, et al.. (2020). Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid. Clinical & Translational Oncology. 22(12). 2364–2368. 64 indexed citations
7.
8.
Franco, Fernando, Juan Carlos Cámara, Ana López‐Alfonso, et al.. (2020). Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting. Clinical & Translational Oncology. 23(4). 812–819. 11 indexed citations
9.
Rogado, Jacobo, et al.. (2020). Covid-19 and lung cancer: A greater fatality rate?. Lung Cancer. 146. 19–22. 84 indexed citations
10.
Serrano, Gabriela, et al.. (2020). 1766P COVID-19 and lung cancer: What do we know?. Annals of Oncology. 31. S1026–S1026.
11.
López‐Alfonso, Ana, Francisco Zambrana, Miriam López-Gómez, et al.. (2020). Prospective analysis of antinuclear antibodies prevalence in a pan-tumor sample.. Journal of Clinical Oncology. 38(15_suppl). e15012–e15012. 1 indexed citations
12.
Franco, Fernando, Juan Carlos Cámara, David Gutiérrez Abad, et al.. (2020). Clinical outcomes of FOLFIRINOX and gemcitabine-nab-paclitaxel for metastatic pancreatic cancer in the real-world setting.. Journal of Clinical Oncology. 38(4_suppl). 656–656. 4 indexed citations
13.
Capdevila, Jaume, José Trigo, Javier Aller, et al.. (2017). Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC). European Journal of Endocrinology. 177(4). 309–317. 29 indexed citations
14.
Rodríguez, Marta, Javier Silva, Ana López‐Alfonso, et al.. (2014). Different exosome cargo from plasma/bronchoalveolar lavage in non‐small‐cell lung cancer. Genes Chromosomes and Cancer. 53(9). 713–724. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emre Yekedüz Breakdown of academic impact, for papers by Clémence Basse Breakdown of academic impact, for papers by Kristen Labbe Breakdown of academic impact, for papers by Nalinie Joharatnam‐Hogan Breakdown of academic impact, for papers by Dana Lucia Stănculeanu Breakdown of academic impact, for papers by Keith A. Dookeran Breakdown of academic impact, for papers by Liang G. Qu Breakdown of academic impact, for papers by Simone Navarra Breakdown of academic impact, for papers by Fabian Echterdiek Breakdown of academic impact, for papers by Davide Soldato
Rankless by CCL
2026